A fast, accurate system for quickly solving stubborn RNA structures from
pond scum, the SARS-CoV-2 virus and more

Date:
August 12, 2021
Source:
DOE/SLAC National Accelerator Laboratory
Summary:
Scientists used a new system to zoom in on an iconic RNA catalyst
and a piece of viral RNA that's a potential target for COVID-19
treatments.



FULL STORY ==========================================================================
The single-stranded genetic material RNA is best known for guiding
the assembly of proteins in our cells and carrying the genetic code for
viruses like SARS- CoV-2 and HIV. But 40 years ago, scientists discovered another hidden talent: It can catalyze chemical reactions in the cell, including snipping and joining RNA strands. This gave new momentum to
the idea that RNA was the driving force behind the evolution of large
molecules that ultimately led to life.


========================================================================== While scientists have learned a lot since then, they haven't been able
to get 3D images of naked RNA molecules in high enough resolution to
see all the pockets and folds and other structures that are key to understanding how they function. The molecules are like fidgety kids
with floppy arms that won't hold still for a photo unless they're part
of a larger molecular complex that pins them in place.

A new system developed at Stanford University and the Department of
Energy's SLAC National Accelerator Laboratory solves that problem. It
combines computer software and cryogenic electron microscopy, or cryo-EM,
to determine the 3D structures of RNA-only molecules with unprecedented
speed, accuracy and resolution.

In two new studies, the research team led by SLAC/Stanford Professor
Wah Chiu and Stanford Professor Rhiju Das push the resolution of the
technique to as high as 3.1 angstroms -- just shy of the point where
individual atoms become visible -- and apply it to two RNA structures
that are of profound interest to scientists.

The first study, published in Nature today, reveals the first full-length, near-atomic structure of a catalytic RNA, or ribozyme, from a one-celled creature called Tetrahymena that lives in pond scum. It was the first
ribozyme ever discovered and has served as a sort of lab rat for studying ribozymes ever since.

The second, which has been posted as a preprint, reveals tiny pockets in
a bit of RNA from SARS-CoV-2 called the frameshift stimulation element,
or FSE. It subtly tricks infected cells into making alternative sets of
viral proteins, and plays such an important role in the virus's ability
to replicate that it remains the same even when other parts of the virus
mutate to create new variants. This makes it a good potential target for
drugs to treat COVID-19, its variants and maybe even other coronaviruses,
and a number of research groups have been exploring that possibility.



==========================================================================
The FSE study was carried out in 2020, at a time when SLAC and Stanford
were shut down due to the pandemic and only essential work related to
the coronavirus response was allowed.

Guided by insights from their 3D structure of FSE, Das's team and
collaborators in Professor Jeff Glenn's lab at Stanford engineered DNA molecules that pair up with a strategic region of the FSE and disrupt
its structure.

While researchers are very far from demonstrating that such a molecule
could thwart viral infection in humans, the study does identify a
potential path for eventually developing a treatment, the scientists said.

"We don't know what the next pandemic virus will be," Das said, "but
we're pretty confident it will be a single-strand RNA virus transmitted
from animals to humans, and it will likely have a few bits of RNA that
resist mutation. With this accelerated system we've developed, it now
seems feasible to study viruses found in humans or animals, look for
those conserved bits, quickly determine their 3D RNA structures and
develop antivirals against them." A passionate pursuit of RNA The two scientists started collaborating in 2017 after Das heard Chiu give a
talk on using cryo-EM to solve the structure of RNA molecules.



==========================================================================
"It blew me away," Das recalled. "I had fallen in love with RNA in 2001. I thought it was the most important molecule of life. The first RNA molecule
I looked at was this Tetrahymena ribozyme. Many, many people had worked
on it - - it was a bit of a cult molecule -- and I spent five years of
my PhD work trying to understand how it folds. So after hearing Wah's
talk I suggested that we work together to determine its structure."
As far as scientists can tell, the ribozyme has no biological function
in Tetrahymena, Das said: "It's an inconsequential molecule in what some
might consider an inconsequential organism." But 40 years ago, when Thomas
Cech discovered that this tiny piece of RNA could cut itself out of a Tetrahymena RNA strand, paste the two loose ends together and float away,
"it was this magical thing that no one expected an RNA strand to do on
its own," Das said.

"They immediately realized that this piece of RNA must be a little
multistep machine -- a catalyst." Cech shared the 1989 Nobel Prize in
Chemistry for the discovery.

Chiu had begun a similar love affair with cryo-EM as a graduate student
at the University of California, Berkeley in the 1970s. Now the founding co-director of the Stanford-SLAC Cryo-EM Facilities, where the imaging
for these studies was done, he has devoted his career to honing the
technique and using it to examine cells and the molecular machines inside
them in finer and finer detail -- not just to see smaller things but to understand how they function and interact with each other.

"It's been a dream of mine to use cryo-EM to study RNA in all its
forms," Chiu said. "I consider getting these RNA structures one of my
top accomplishments.

If we can do this with one molecule, in theory we can do it with many
others." Developing an RNA pipeline Das and Chiu's work builds on
Ribosolve, a pipeline their groups developed in the two years prior to
the pandemic that allows them to quickly solve the structures of RNAs one
right after another, more reliably and in much more detail than before. It combines computational tools developed by Stanford PhD student Kalli
Kappel with chemical mapping tools from the Das lab and cryo-EM imaging advances from postdoctoral researchers Kaiming Zhang and Zhaoming Su.

In a paper in Nature Methods last year, the team reported using the new approach to determine the 3D structures of the Tetrahymena ribozyme and
10 other RNA molecules with better than 10 angstrom resolution.

"Each of these 11 new structures turned out to provide biological
or biochemical insights," wrote Jane S. Richardson, a professor of
biochemistry at Duke University, in a commentary that accompanied
the report. She called the approach a "groundbreaking new method" that
produces fast and reliable structures of RNA-only molecules that were not considered feasible before, and added that increasing the resolution to
2-4 angstroms would be a desirable demonstration of its usefulness for
both RNA and proteins.

In their new Nature paper, the team reports that it has now achieved
that higher resolution for the Tetrahymenaribozyme and is hoping to push
toward it for FSE, with the ultimate goal of producing atomic-resolution structures for these and potentially thousands of other RNAs.

"I do think the Ribosolve pipeline has the potential to transform our understanding of these molecules, and maybe our ability to develop
medicines, too," Das said. "This couldn't have happened anywhere
else. Having access to world-class cryo-EM instruments was key, along
with meeting someone like Wah who shared our intuition that this could
be important." Work on the Tetrahymena ribozyme was supported by the
National Institutes of Health.

Researchers from the University of North Carolina and Harvard University
also contributed to the work on the SARS-CoV-2 FSE. It was supported
by the National Institutes of Health and the DOE Office of Science
through the National Virtual Biotechnology Laboratory, a consortium of
DOE national laboratories focused on response to COVID-19, with funding provided by the Coronavirus CARES Act.

========================================================================== Story Source: Materials provided by
DOE/SLAC_National_Accelerator_Laboratory. Original written by Glennda
Chui. Note: Content may be edited for style and length.


========================================================================== Journal References:
1. Zhaoming Su, Kaiming Zhang, Kalli Kappel, Shanshan Li, Michael
Z. Palo,
Grigore D. Pintilie, Ramya Rangan, Bingnan Luo, Yuquan
Wei, Rhiju Das, Wah Chiu. Cryo-EM structures of full-length
Tetrahymena ribozyme at 3.1 AA resolution. Nature, 2021; DOI:
10.1038/s41586-021-03803-w
2. Kaiming Zhang, Ivan N. Zheludev, Rachel J. Hagey, Marie Teng-Pei Wu,
Raphael Haslecker, Yixuan J. Hou, Rachael Kretsch, Grigore
D. Pintilie, Ramya Rangan, Wipapat Kladwang, Shanshan Li, Edward
A. Pham, Claire Bernardin-Souibgui, Ralph S. Baric, Timothy
P. Sheahan, Victoria D'souza, Jeffrey S. Glenn, Wah Chiu, Rhiju
Das. Cryo-electron Microscopy and Exploratory Antisense Targeting
of the 28-kDa Frameshift Stimulation Element from the SARS-CoV-2
RNA Genome. bioRxiv, July 20, 2020; DOI: 10.1101/2020.07.18.209270 ==========================================================================

Link to news story: https://www.sciencedaily.com/releases/2021/08/210812092734.htm

--- up 13 weeks, 6 days, 22 hours, 45 minutes
* Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)